Literature DB >> 30136128

Severe hypermagnesemia induced by magnesium oxide ingestion: a case series.

Hiroki Yamaguchi1,2, Hisaki Shimada3, Kazuhiro Yoshita3, Yutaka Tsubata3, Kouzou Ikarashi3, Tetsuo Morioka3, Noriko Saito3, Shinji Sakai3, Ichiei Narita4.   

Abstract

Hypermagnesemia is generally considered an exceptional iatrogenic condition usually caused by magnesium-containing cathartics. In particular, this condition often develops when magnesium-containing cathartics are administered to elderly patients with renal insufficiency or bowel movement dysfunction. Although magnesium oxide (MgO) is widely prescribed as a laxative, serum magnesium concentration has not been examined in most cases. In this report, we present the cases of four elderly patients with constipation and symptomatic hypermagnesemia caused by MgO ingestion, one of which had a lethal course. All of the patients were older than 65 years and with renal dysfunction. In addition, they had difficulties in expressing their symptoms because of cerebrovascular events or dementia. These cases suggest that hypermagnesemia caused by magnesium-containing cathartics is more likely to develop than previously recognized and that physicians should be aware that patients with chronic kidney disease and the elderly are at risk of hypermagnesemia on magnesium administration. We recommend serum magnesium monitoring for high-risk patients after initial prescription or dose increase.

Entities:  

Keywords:  Cathartic; Chronic kidney disease; Constipation; Hypermagnesemia; Magnesium oxide

Mesh:

Substances:

Year:  2018        PMID: 30136128      PMCID: PMC6361089          DOI: 10.1007/s13730-018-0359-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  18 in total

1.  The effect of intravenous parathyroid extract on urinary pH, bicarbonate and electrolyte excretion.

Authors:  B E NORDIN
Journal:  Clin Sci       Date:  1960-05       Impact factor: 6.124

2.  Calcium-alkali syndrome due to vitamin D administration and magnesium oxide administration.

Authors:  Shigeru Hanada; Mari Iwamoto; Namiko Kobayashi; Ryoichi Ando; Sei Sasaki
Journal:  Am J Kidney Dis       Date:  2009-01-29       Impact factor: 8.860

3.  Intestinal absorption of magnesium from food and supplements.

Authors:  K D Fine; C A Santa Ana; J L Porter; J S Fordtran
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 4.  Disorders involving calcium, phosphorus, and magnesium.

Authors:  Sharon M Moe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

Review 5.  A critical role of TRPM channel-kinase for human magnesium transport.

Authors:  Karl P Schlingmann; Thomas Gudermann
Journal:  J Physiol       Date:  2005-04-21       Impact factor: 5.182

6.  Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without pre-existing renal dysfunction.

Authors:  Makoto Kontani; Akinori Hara; Shinji Ohta; Takayuki Ikeda
Journal:  Intern Med       Date:  2005-05       Impact factor: 1.271

7.  Circulatory collapse caused by unnoticed hypermagnesemia in a hospitalized patient.

Authors:  MinHye So; Hiroaki Ito; Kazuya Sobue; Takako Tsuda; Hirotada Katsuya
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

8.  Intracellular Mg2+ and magnesium depletion in isolated renal thick ascending limb cells.

Authors:  L J Dai; G A Quamme
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 9.  Cathartic-induced fatal hypermagnesemia in the elderly.

Authors:  Sachiko Onishi; Shunpei Yoshino
Journal:  Intern Med       Date:  2006-03-15       Impact factor: 1.271

10.  Unsuspected morbid hypermagnesemia in elderly patients.

Authors:  B A Clark; R S Brown
Journal:  Am J Nephrol       Date:  1992       Impact factor: 3.754

View more
  2 in total

Review 1.  Magnesium Oxide in Constipation.

Authors:  Hideki Mori; Jan Tack; Hidekazu Suzuki
Journal:  Nutrients       Date:  2021-01-28       Impact factor: 5.717

2.  Severe Hypermagnesemia with Normal Renal Function Can Improve with Symptomatic Treatment.

Authors:  Yoshiaki Ishida; Akihiko Tabuchi
Journal:  Case Rep Emerg Med       Date:  2020-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.